HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ian J Martins Selected Research

Therapeutics

1/2020Sodium Butyrate Reduces Brain Amyloid-β Levels and Improves Cognitive Memory Performance in an Alzheimer's Disease Transgenic Mouse Model at an Early Disease Stage.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ian J Martins Research Topics

Disease

8Alzheimer Disease (Alzheimer's Disease)
01/2020 - 01/2009
5Obesity
03/2017 - 02/2002
3Cognitive Dysfunction
01/2020 - 01/2009
2Atherosclerosis
05/2002 - 02/2002
1Inflammation (Inflammations)
10/2021
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2020
1Disease Progression
01/2020
1Memory Disorders (Memory Loss)
01/2020
1Type 2 Diabetes Mellitus (MODY)
07/2015
1Hypertension (High Blood Pressure)
07/2015
1Insulin Resistance
07/2015
1Coronary Artery Disease (Coronary Atherosclerosis)
12/2009
1Cardiovascular Diseases (Cardiovascular Disease)
01/2009
1Dyslipidemias (Dyslipidemia)
03/2004
1Hyperphagia (Overeating)
03/2004
1Hereditary Sensory and Motor Neuropathy (Dejerine Sottas Disease)
08/2003
1Neoplasms (Cancer)
08/2003
1LOM type hereditary motor and sensory Neuropathy
08/2003
1Abdominal Obesity
05/2002

Drug/Important Bio-Agent (IBA)

3Lipoproteins (Lipoprotein)IBA
03/2017 - 02/2002
3ApolipoproteinsIBA
01/2010 - 01/2009
2LipidsIBA
03/2017 - 03/2004
2Apolipoproteins E (ApoE)IBA
01/2010 - 12/2009
2CholesterolIBA
12/2009 - 03/2004
2IsotopesIBA
05/2002 - 02/2002
2Chylomicron RemnantsIBA
05/2002 - 02/2002
1N,N-dimethylarginine (asymmetric dimethylarginine)IBA
10/2021
1symmetric dimethylarginineIBA
10/2021
1acylcarnitineIBA
10/2021
1Amino AcidsFDA Link
10/2021
1Arginine (L-Arginine)FDA Link
10/2021
1AsparagineIBA
10/2021
1Biogenic Amines (Biogenic Amine)IBA
10/2021
1CitrullineIBA
10/2021
1CreatinineIBA
10/2021
1Hydroxyproline (4 Hydroxyproline)IBA
10/2021
1KynurenineIBA
10/2021
1Nitric Oxide (Nitrogen Monoxide)FDA Link
10/2021
1Phenylalanine (L-Phenylalanine)FDA Link
10/2021
1Proline (L-Proline)FDA Link
10/2021
1Threonine (L-Threonine)FDA Link
10/2021
1Neurotransmitter Agents (Neurotransmitter)IBA
10/2021
1Peptides (Polypeptides)IBA
01/2020
1Butyric Acid (Butanoic Acid)IBA
01/2020
1Histone Deacetylase InhibitorsIBA
01/2020
1Amyloid (Amyloid Fibrils)IBA
01/2020
1ZincIBA
09/2015
1VitaminsIBA
07/2015
1oxidized low density lipoproteinIBA
07/2015
1Ketone BodiesIBA
07/2015
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2012
1InterleukinsIBA
06/2012
1Indicators and Reagents (Reagents)IBA
01/2009
1Amyloid beta-PeptidesIBA
01/2009
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
03/2004
1RNA Splice SitesIBA
08/2003
1Heavy MetalsIBA
08/2003
1Proteins (Proteins, Gene)FDA Link
08/2003
1Atorvastatin (Lipitor)FDA Link
05/2002
1Triglycerides (Triacylglycerol)IBA
02/2002

Therapy/Procedure

1Therapeutics
01/2020